Country websites

Fresenius Medical Care at ASN Kidney Week 2026

October 21-25, 2026
Denver, Colorado, U.S.

As the world's leading nephrology meeting, the American Society of Nephrology’s (ASN) Kidney Week 2026 brings together kidney care professionals, researchers, and industry leaders from around the globe to share knowledge, explore the latest scientific advances, and engage in meaningful discussions about the future of kidney health.

Fresenius Medical Care (FME) is proud to participate in this year's meeting, reflecting our ongoing commitment to advancing kidney care through innovation, research, and collaboration. Throughout the conference, attendees will have opportunities to connect with our experts, learn about emerging clinical evidence, and explore solutions designed to improve outcomes for patients worldwide.

Symposiums and exhibitions

On Tuesday, October 20, the Renal Research Institute (RRI) will host its annual symposium entitled “From CONVINCE to Clinical Practice: Translating HDF Evidence into Real-World Care”, an expert-led symposium exploring the evolving evidence around high-volume hemodiafiltration (HDF) and what comes next for research and clinical practice.

The program will bring together leading international experts to examine findings from CONVINCE, real-world evidence, emerging research approaches, and the questions shaping the next generation of HDF evidence.

View the full program and register to attend through the RRI Symposium registration site.

On Friday, October 23, the American Society of Nephrology will present a CE-accredited symposium entitled “Hemodiafiltration in 2026: Rationale, Evidence, and the Path to Implementation” from 12:45 to 1:45 p.m. MDT. This educational symposium will offer a review of hemodiafiltration including its physiologic rationale, clinical data, evidence gaps, and practical considerations for implementation in dialysis practice. 

Attendance is available on a first-come, first-served basis to fully paid Annual Meeting participants. Support is provided by an educational grant from Fresenius Medical Care.

Learn more about this symposium here.

Networking events for nephrology fellows

The FME Physician Placement team invites all fellows in training to a social event on Friday, October 23. Fellows are welcome to mingle with colleagues, get free professional headshots, and meet with Fresenius Kidney Care affiliated hiring practices and FME physician support teams. 

Fellows may RSVP by clicking here.

Visit Our Exhibits

Fresenius Medical Care representatives will be available throughout Kidney Week to discuss our research, products, services, and innovations. We invite attendees to visit our exhibit spaces to connect with our teams and learn more about how we are working to advance kidney care and improve the lives of patients around the world.


Fresenius Medical Care

Booth #571

Fresenius Medical Care is the global leader in kidney care technology, combining decades of specialized expertise with the industry’s most comprehensive dialysis portfolio across every major dialysis modality. From in-center dialysis and home therapies to critical care, we continue to advance the field with innovations that expand treatment options while helping providers improve patient outcomes and drive greater operational efficiency.


Renal Research Institute

Booth #255

Visit the RRI booth at ASN Kidney Week 2026 to learn more about RRI’s capabilities across Clinical Evidence Generation, Clinical AI and Generative AI, Computational Medicine and Mathematical Modeling, and Data Analytics and Stewardship. The booth will also provide an opportunity to meet members of the RRI team and connect around potential collaborations with academic institutions, kidney care organizations, and other partners.

2026 ASN accepted abstracts list

FME researchers will present numerous posters and scientific abstracts highlighting insights across a broad range of kidney care topics, including hemodiafiltration, artificial intelligence, patient outcomes, and clinical research.

A summary of all accepted abstracts appears below. You can also read the press release about FME’s presence at ASN here.

CountTitleFirst AuthorTopicSubmission Number
1Predicting Bicarbonate Dynamics During CKRT - Model Validation and Detection of Complications in a U.S. CohortSabrina CasperCKRTTH-PO0737
2Vascular access–specific patterns of intravenous antibiotic use among hemodialysis patients inApolloDialDbAnke WinterHD / HDFTH-PO0961
3A 30-Day Risk Prediction Model for Recovery, ESKD, or Death in AKI-D Patients Receiving Outpatient HemodialysisAndrea Nandorine BanMetrics & ModelingTH-PO0715
4Dynamics of Plasma Refill Rate Relative to Ultrafiltration Rate During HemodialysisSheng-Han YuehHD / HDFTH-PO0857
5Intradialytic Changes of Upper Body Blood Flow (UBBF) and UBBF-derived Cardiac Power Output - Findings in a Large Population of Hemodialysis Patients with Central Venous Catheter as Vascular AccessSheng-Han YuehHD / HDFTH-PO0858
6Metabolite Removal by High-Flux Hemodialysis (HFX-HD) and High-volume Hemodiafiltration (hvHDF): A Cross-Over StudyXiaoling WangHD / HDFTH-PO0855
7Calcium Control and Electrolyte Stability During Regional Citrate Anticoagulation Using a Fully Integrated CRRT System: Insights from a Prospective Multicenter StudyLenar YessayanOtherTH-PO0729
8Dialysate Conservation Among Hemodialysis Patients Transitioning to Hemodiafiltration With AutoSub PlusMeijiao ZhouHD / HDFTH-PO0867
9High-Volume Hemodiafiltration in the United States - Real-World Achievement of Target Convective DoseLinda FicocielloMetrics & ModelingTH-PO0872
10Total Body Water-Standardized Convection Volume and Survival in Hemodiafiltration PatientsYan ZhangHD / HDFTH-PO0854
11Changes in Dialysate Prescription and Serum Electrolytes Following Transition to Hemodiafiltration With AutoSub Plus in a U.S. Maintenance Dialysis PopulationCarly R. Van ZandtHD / HDFTH-OR089
12Treatment modality-specific patterns of antibiotic use in US dialysis patientsFelix J. MeigelOtherFR-PO1106
13A Large Language Model-Driven Strategy for High-Precision Abstract Screening in Systematic ReviewsKarin BerglingAI / LLMFR-PO0038
14AI-Based Extraction and Temporal Classification of Symptoms and Signs from Hemodialysis NotesKarin BerglingAI / LLMFR-PO0035
15AI-Enhanced Extraction of Candida auris Testing Results from Health Information Exchange Data in a Dialysis PopulationKarin BerglingAI / LLMFR-PO0034
16Comparative Performance of Five Large Language Models in Systematic Review Abstract ScreeningKarin BerglingAI / LLMFR-PO0036
17Extreme Heat Exposure and Changes in Pre-Hemodialysis Blood Pressure – A National Assessment Nicole SieckHD / HDFFR-PO1044
18Improving Literature Screening Efficiency with Large Language Model-Assisted Abstract TriageKarin BerglingAI / LLMFR-PO0037
19Trajectory-Based Machine Learning Reveals Progressive Mortality Risk Escalation Prior to Death in Hemodialysis PatientsRadek HolikAI / LLMFR-PO0007
20Itching to Know - Does Dialysis Vintage Impact the Global and Regional Prevalence of PruritusYue JiaoHD / HDFFR-PO1035
21Longitudinal Benchmarking of GPT-4o and GPT-5.4 for Nutrient Estimation in Culturally Diverse Hemodialysis Meal PlansLin-Chun WangAI / LLMFR-PO0055
22Patient-reported dialysis recovery time before and after the initiation of HDFRachel LaskyHD / HDFFR-PO1058
23Protocol for a Qualitative Study of Lived Experiences with Hemodiafiltration in US AdultsMiriam Velez-BermudezPatient HealthFR-PO1051
24Quality of Life in Incident Dialysis - A Global PreviewKaitlyn CroftPatient HealthFR-PO0051
25Construct Validation of an IRT-Derived Intradialytic Symptom Score Using KDQoL-36 and Recovery TimeJasmine Ion TitapiccoloMetrics & ModelingFR-PO1025
26Global Profiles of Quality of Life by Age in Prevalent Dialysis - A Global Report by ApolloDialDb InitiativeSamuele AloiPatient HealthFR-PO1032
27Regional Differences in Quality of Life in Prevalent Dialysis - An ApolloDialDb Initiative ReportSamuele AloiPatient HealthFR-PO1033
28Continuous relative blood volume analysis reveals patient-specific plasma refill profilesFelix J. MeigelHD / HDFSA-PO1095
29Continuous Oxygen Monitoring Reveals Link Between Arterial Oxygen Saturation Oscillations and Mortality Risk in Hemodialysis PatientsAndrea Nandorine BanHD / HDFSA-PO1079
30Effect of Prediction Horizons on Machine Learning Mortality Models in Hemodialysis PatientsRadek HolikAI / LLMSA-PO0085
31Intradialytic Dynamics of Upper Body Blood Flow (UBBF) and UBBF-derived Cardiac Power Output inHemodialysis Patients with Central Venous Catheter as Vascular AccessSheng-Han YuehHD / HDFSA-PO1041
32Solution to the Tsunami of High-Frequency Dialysis Machine Data: Information Preservation by an AI Autoencoder SystemSheng-Han YuehAI / LLMSA-PO0079
33Physical Activity Fragmentation and Mortality in Hemodialysis Patients - results from a prospective observational studyMaggie HanPatient HealthSA-PO1010
34Application of American Society for Apheresis (ASFA) Guidline Recommendations for Therapeutic Plasma Exchange (TPE): A Scoping Review of Published LiteratureJana SchmittOtherSA-PO1113
35Comparison of Blood Stream Infections in Patients Using ClearGuard or DefenCathRachel LaskyOtherSA-PO1068
36Convective volume, body size and mortality in hemodiafiltration: an individual patient data analysis of randomized trialsKrister CrommHD / HDFSA-PO1065
37Measurement Precision Matters: PROPr Detects Treatment Effects Mssed by EQ-5D-5L in the CONVINCE Randomized TrialChristoph Paul KlapprothOtherSA-PO1066 
38Pre-Dialysis Care (pdCKD) and Early Outcomes After Dialysis Initiation - The Mediating Role ofVascular Access and Modifiable Factors at Dialysis Start in a European Multi-Country CohortLuca NeripdCKDSA-PO1104
39Pharmacy-Led Outreach Supports Phosphate Binder Access After Dialysis Bundle ExpansionAmanda MartinezOtherSA-PO1088
40Real-World Mortality and Hospitalization Outcomes Associated With GLP-1 Receptor Agonist Use in Dialysis PatientsSuman LamaOtherSA-PO0427
41Unsupervised Machine Learning Clustering or Risk Profiles in Dialysis PatientsMelanie WolfAI / LLMSA-PO0084
42Longitudinal Decline in Daily Step Count Is Associated with Mortality in Patients on Maintenance HemodialysisMaggie HanPatient HealthSA-OR024
43Body Mass and Cardiovascular Events/Mortality in the 2019 MONDO Hemodialysis CohortPo ChouPatient HealthSA-OR023
44Interrelationships Among Dialysis Quality MetricsDerek M. BlankenshipMetrics & ModelingFR-PO1055
45Near-Real-Time Surveillance of US 5008x High-Volume Hemodiafiltration - An AI-Accelerated Real-World Evidence PlatformDerek M. BlankenshipAI / LLMTH-PO0875

Research in Brief

Explore our Research in Brief video series, featuring nephrology experts at Fresenius Medical Care and the Renal Research Institute as they explain the key ideas in their research that help advance kidney disease care.


Online hemodiafiltration and medium cut-off dialyzers 


Why lean tissue index matters in HDF


Estimated dialysate and water savings with HVHDF